Medicare Enrolled

Dr. Erik Weise, MD

Urology Physician · Centerville, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2350 MIAMI VALLEY DR STE 500, Centerville, OH 45459
9372931622
In practice since 2006 (20 years)
NPI: 1336113604 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weise from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weise? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weise

Dr. Erik Weise is an urology physician in Centerville, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Weise performed 4,872 Medicare services across 986 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weise received a total of $9,226 from 40 pharmaceutical and/or device companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weise is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 7% volume in OH $9,226 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,872
Medicare services
Top 7% in OH for urology physician
986
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~244 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 3,400 $2 $6
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
383 $2 $15
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
163 $167 $450
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
141 $59 $110
Leuprolide acetate (for depot suspension), 7.5 mg 115 $137 $457
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
81 $127 $281
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
68 $62 $283
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
59 $19 $272
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
46 $96 $222
Endoscopic removal of pelvic lymph nodes, bilateral
A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue.
36 $254 $1,523
New patient office visit, complex (60-74 min) 36 $167 $402
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
32 $134 $399
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
30 $7 $43
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
29 $81 $847
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
27 $92 $156
Surgical removal of prostate and lymph nodes
This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope.
25 $916 $3,325
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
24 $49 $200
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
22 $23 $84
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
18 $21 $167
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $113 $320
Endoscopic biopsy and removal of abdominal lymph nodes
A procedure to examine and remove lymph nodes in the abdominal cavity using an endoscope. The endoscope allows the provider to access the area through a small incision.
17 $191 $1,090
Partial kidney removal using endoscope
Surgical removal of part of the kidney through a small incision using an endoscope. This minimally invasive technique allows for targeted tissue removal without large open incisions.
17 $1,138 $3,044
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $65 $207
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
16 $38 $67
Emergency department visit, low level of medical decision making
An emergency department visit for a patient requiring a low level of medical decision making.
14 $56 $123
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
14 $64 $200
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
13 $239 $885
Kidney cyst destruction via endoscope
A procedure to destroy a cyst in the kidney using an endoscope. The endoscope is inserted to access and treat the cyst.
11 $383 $1,757
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
3.0% medium
96.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,226
Total received (2018-2024)
Avg $1,318/year across 7 years
Top 19% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
89
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,196 (67.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,030 (32.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,298
2023
$392
2022
$239
2021
$95
2020
$76
2019
$1,826
2018
$300

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$6,172
Merck Sharp & Dohme LLC
$30
Laborie Medical Technologies Corp.
$28
C. R. Bard, Inc. & Subsidiaries
$24
Novartis Pharmaceuticals Corporation
$23
Myriad Genetic Laboratories, Inc.
$20
Top 3 companies account for 98.9% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$6,172
Intuitive Surgical, Inc.
$1,780
Astellas Pharma US Inc
$119
UroGen Pharma, Inc.
$96
UROVANT SCIENCES INC
$75
Amniox Medical, Inc.
$67
Merck Sharp & Dohme LLC
$61
TOLMAR Pharmaceuticals, Inc.
$55
Amgen Inc.
$53
Sumitomo Pharma America, Inc.
$51
CONMED Corporation
$44
Novartis Pharmaceuticals Corporation
$41
Dendreon Pharmaceuticals LLC
$39
Rochester Medical Corporation
$38
EDAP TECHNOMED INC
$34
Myriad Genetic Laboratories, Inc.
$32
PFIZER INC.
$31
Laborie Medical Technologies Corp.
$28
Ethicon US, LLC
$26
Cardinal Health 108, LLC
$26
C. R. Bard, Inc. & Subsidiaries
$24
GENZYME CORPORATION
$24
Coloplast Corp
$24
Axonics, Inc.
$23
Boston Scientific Corporation
$22
COLOPLAST CORP
$20
Blue Earth Diagnostics Limited
$20
Foundation Medicine, Inc.
$20
Janssen Biotech, Inc.
$20
Merck Sharp & Dohme Corporation
$19
KOELIS Inc.
$16
AbbVie Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
Endo Pharmaceuticals Inc.
$15
Olympus America Inc.
$14
ACCORD HEALTHCARE, INC.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
AbbVie, Inc.
$13
DENTSPLY IH Inc.
$12
Axonics Modulation Technologies, Inc.
$11
Top 3 companies account for 87.5% of all-time payments
Associated products mentioned in payments ›
AirSeal · Axonics · Axonics r-SNM System · Axumin · Bard Urinary Drainage Bag · CAMCEVI · DA VINCI SP · Da Vinci Surgical System · ELIGARD · Erleada · GEMTESA · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · MONOCRYL · MYRBETRIQ · Myrbetriq · NEOX · Olympus Cystoscopes · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Prolia · SPACEOAR · SPEEDICATH · SUTENT · SpeediCath · Trinity · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for an urology physician in Centerville?
Compare urology physicians in the Centerville area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
39
Per 100K population
7.3
County median income
$64,403
Nearest hospital
KETTERING HEALTH MAIN CAMPUS
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weise is a mixed practice specialist, with above-average Medicare volume (top 7% in OH), with speaking/promotional industry engagement in the top 19% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weise experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Weise performed 3,400 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weise receive payments from pharmaceutical companies?
Yes. Dr. Weise received a total of $9,226 from 40 companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weise's costs compare to other urology physicians in Centerville?
Dr. Weise's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weise) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →